Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, Inspire Medical Systems, Inc. reported revenue of $912M, up 13.6% year over year. Operating margin was 5.6% and net margin 15.9%, on a free-cash-flow margin of 8.6% with capital expenditure at 4.2% of revenue. Every figure is computed directly from INSP's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $912M | 5.6% | 15.9% |
| FY2024 | $803M | 4.5% | 6.7% |
| FY2023 | $625M | -6.4% | -3.4% |
| FY2022 | $408M | -11.7% | -11.0% |
| FY2021 | $233M | -17.1% | -18.0% |
How does INSP compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: A · ACHR · AEHR · AERG · AEVA · AIRI
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.